Objectives:
To develop evidence-based recommendations for clinicians caring for adults with acute or acute on chronic liver failure in the ICU.
Design:
The guideline panel comprised 29 members with expertise in aspects of care of the critically ill patient with liver failure and/or methodology. The Society of Critical Care Medicine standard operating procedures manual and conflict-of-interest policy were followed throughout. Teleconferences and electronic-based discussion among the panel, as well as within subgroups, served as an integral part of the guideline development.
Setting:
The panel was divided into nine subgroups: cardiovascular, hematology, pulmonary, renal, endocrine and nutrition, gastrointestinal, infection, perioperative, and neurology.
Interventions:
We developed and selected population, intervention, comparison, and outcomes questions according to importance to patients and practicing clinicians. For each population, intervention, comparison, and outcomes question, we conducted a systematic review aiming to identify the best available evidence, statistically summarized the evidence whenever applicable, and assessed the quality of evidence using the Grading of Recommendations Assessment, Development, and Evaluation approach. We used the evidence to decision framework to facilitate recommendations formulation as strong or conditional. We followed strict criteria to formulate best practice statements.
Measurements And Main Results:
In this article, we report 29 recommendations (from 30 population, intervention, comparison, and outcomes questions) on the management acute or acute on chronic liver failure in the ICU, related to five groups (cardiovascular, hematology, pulmonary, renal, and endocrine). Overall, six were strong recommendations, 19 were conditional recommendations, four were best-practice statements, and in two instances, the panel did not issue a recommendation due to insufficient evidence.
Conclusions:
Multidisciplinary international experts were able to formulate evidence-based recommendations for the management acute or acute on chronic liver failure in the ICU, acknowledging that most recommendations were based on low-quality indirect evidence.
Citing Articles
Expert consensus on liver transplantation perioperative evaluation and rehabilitation for acute-on-chronic liver failure.
Lv H, Zheng H, Liu J, Cai Q, Ren Y, Yi H
Liver Res. 2025; 6(3):121-129.
PMID: 39958201
PMC: 11791836.
DOI: 10.1016/j.livres.2022.08.002.
Viscoelastic haemostatic assays to guide therapy in elective surgery: an updated systematic review and meta-analysis.
Dias J, Levy J, Tanaka K, Zacharowski K, Hartmann J
Anaesthesia. 2024; 80(1):95-103.
PMID: 39544008
PMC: 11617132.
DOI: 10.1111/anae.16463.
Should viscoelastic testing be a standard point-of-care test on all intensive care units?.
Natasha Passi N, Parker T
J Intensive Care Soc. 2024; 25(4):432-439.
PMID: 39524069
PMC: 11549721.
DOI: 10.1177/17511437241290154.
An artificial neural network approach to diagnose and predict liver dysfunction and failure in the critical care setting.
Pappada S, Sathelly B, Schmieder J, Javaid A, Owais M, Cameron B
Hippokratia. 2024; 28(1):1-10.
PMID: 39399402
PMC: 11466107.
Adverse Events and Outcomes of High-volume Plasma Exchange in 50 Acute Liver Failure Patients: A Monocentric Retrospective Real-world Study.
Coirier V, Quelven Q, Guillot P, Delamaire F, Houssel-Debry P, Maamar A
J Clin Exp Hepatol. 2024; 15(1):101934.
PMID: 39268478
PMC: 11387678.
DOI: 10.1016/j.jceh.2024.101934.
Low Baseline but Not Delta Cortisol Relates to 28-Day Transplant-Free Survival in Acute and Acute-on-Chronic Liver Failure.
Roth S, Flint E, Ghataore L, Patel V, Singanayagam A, Vincent R
Gastro Hep Adv. 2024; 2(1):72-82.
PMID: 39130154
PMC: 11308052.
DOI: 10.1016/j.gastha.2022.08.006.
No Significant Beneficial Effects of Intravenous N-Acetylcysteine on Patient Outcome in Non-Paracetamol Acute Liver Failure: A Meta-Analysis of Randomized Controlled Trials.
Orban C, Agapie M, Bratu A, Jafal M, Dutu M, Popescu M
Biomedicines. 2024; 12(7).
PMID: 39062036
PMC: 11274394.
DOI: 10.3390/biomedicines12071462.
Development and validation of a new prognostic model for patients with acute-on-chronic liver failure in intensive care unit.
Zhu Z, Huang X, Jiang H, Liu L
World J Gastroenterol. 2024; 30(20):2657-2676.
PMID: 38855159
PMC: 11154676.
DOI: 10.3748/wjg.v30.i20.2657.
Comparison of fungal bacterial infections in the medical intensive liver unit: Cause or corollary for high mortality?.
Khan S, Hong H, Bass S, Wang Y, Wang X, Sims O
World J Hepatol. 2024; 16(3):379-392.
PMID: 38577538
PMC: 10989308.
DOI: 10.4254/wjh.v16.i3.379.
Extra-corporeal non-liver transplant therapies for acute liver failure: Focus on plasma exchange and continuous renal replacement therapy.
Zachariah U, Vijayalekshmi B, Matthai S, Goel A, Eapen C
Indian J Gastroenterol. 2024; 43(2):338-348.
PMID: 38530631
DOI: 10.1007/s12664-024-01558-6.
Predictive effect of systemic immune inflammatory index combined with neutrophil-to-lymphocyte ratio on prognosis of patients with acute-on-chronic liver failure.
He X, Lin Y, Qiu H, Wang X, Zhu B
Am J Transl Res. 2024; 15(12):6841-6848.
PMID: 38186984
PMC: 10767542.
Stem Cell-Based Strategies: The Future Direction of Bioartificial Liver Development.
Feng L, Wang Y, Fu Y, Li T, He G
Stem Cell Rev Rep. 2024; 20(3):601-616.
PMID: 38170319
DOI: 10.1007/s12015-023-10672-5.
Thromboelastography-Guided Correction of Coagulopathy Before Tunneled Central Venous Access in Critically Ill Patients With Liver Disease: A Propensity Score-Matched Study.
Sohail M, Vachharajani T, Lane J, Huang S, Wang X, Mucha S
Crit Care Explor. 2023; 5(12):e1023.
PMID: 38115819
PMC: 10730036.
DOI: 10.1097/CCE.0000000000001023.
Identification of oxidative stress-related biomarkers associated with the development of acute-on-chronic liver failure using bioinformatics.
Zhu Z, Jiang H
Sci Rep. 2023; 13(1):17073.
PMID: 37816833
PMC: 10564851.
DOI: 10.1038/s41598-023-44343-9.
The patient with cirrhosis in the intensive care unit and the management of acute-on-chronic liver failure.
Passi N, McPhail M
J Intensive Care Soc. 2023; 23(1):78-86.
PMID: 37593538
PMC: 10427846.
DOI: 10.1177/1751143720978849.
Intensive care management of acute-on-chronic liver failure.
Perricone G, Artzner T, De Martin E, Jalan R, Wendon J, Carbone M
Intensive Care Med. 2023; 49(8):903-921.
PMID: 37552333
DOI: 10.1007/s00134-023-07149-x.
Acute-On-Chronic Liver Failure: Current Interventional Treatment Options and Future Challenges.
Kimmann M, Trebicka J
J Pers Med. 2023; 13(7).
PMID: 37511665
PMC: 10381861.
DOI: 10.3390/jpm13071052.
Future directions in acute liver failure.
Stravitz R, Fontana R, Karvellas C, Durkalski V, McGuire B, Rule J
Hepatology. 2023; 78(4):1266-1289.
PMID: 37183883
PMC: 10521792.
DOI: 10.1097/HEP.0000000000000458.
Stress granules inhibit endoplasmic reticulum stress-mediated apoptosis during hypoxia-induced injury in acute liver failure.
Li W, Yang F, Li X, Wang L, Wang Y
World J Gastroenterol. 2023; 29(8):1315-1329.
PMID: 36925453
PMC: 10011964.
DOI: 10.3748/wjg.v29.i8.1315.
Viscoelastic testing: an illustrated review of technology and clinical applications.
Hartmann J, Hermelin D, Levy J
Res Pract Thromb Haemost. 2023; 7(1):100031.
PMID: 36760779
PMC: 9903681.
DOI: 10.1016/j.rpth.2022.100031.